Synthesis and assessment of phenylacrylamide derivatives as potential anti-oxidant and anti-inflammatory agents. 2019

Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China. Electronic address: gu_xk@xzhmu.edu.cn.

Oxidative stress and inflammation are major causes of numerous life-threatening human diseases. In the present study, we synthesized a series of phenylacrylamide derivatives as novel anti-oxidant and anti-inflammatory agents. Biological evaluation showed that compound 6a could more potently protect HBZY-1 mesangial cells from H2O2-caused oxidative stress than positive controls resveratrol and sulforaphane by dose- and time-dependently impairing the ROS accumulation. Preliminary anti-oxidant mechanism studies indicated that compound 6a could activate Nrf2 and increase the protein and mRNA expression of downstream anti-oxidant enzymes, ie. NQO-1, HO-1, GCLM and GCLC. Notably, 6a could inhibit the production of NO and the activity of NF-κB in LPS-stimulated HBZY-1 mesangial cells, indicating its potential anti-inflammatory activity. Interestingly, both effects could be significantly attenuated by Nrf2 inhibitor TRG, HO-1 inhibitor ZnPP or GCL inhibitor BSO at non-toxic concentrations, confirming that the anti-oxidant and anti-inflammatory activity of 6a is related to the activation of Nrf2 signaling pathway. These results, together with the relatively safety profile, indicated that compound 6a could be a promising lead to develop novel anti-oxidant and anti-inflammatory agents, thus preventing diseases induced by oxidative stress and inflammation.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006861 Hydrogen Peroxide A strong oxidizing agent used in aqueous solution as a ripening agent, bleach, and topical anti-infective. It is relatively unstable and solutions deteriorate over time unless stabilized by the addition of acetanilide or similar organic materials. Hydrogen Peroxide (H2O2),Hydroperoxide,Oxydol,Perhydrol,Superoxol,Peroxide, Hydrogen
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D057809 HEK293 Cells A cell line generated from human embryonic kidney cells that were transformed with human adenovirus type 5. 293T Cells,HEK 293 Cell Line,HEK 293 Cells,Human Embryonic Kidney Cell Line 293,Human Kidney Cell Line 293,293 Cell, HEK,293 Cells, HEK,293T Cell,Cell, 293T,Cell, HEK 293,Cell, HEK293,Cells, 293T,Cells, HEK 293,Cells, HEK293,HEK 293 Cell,HEK293 Cell

Related Publications

Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
July 2020, Bioorganic & medicinal chemistry letters,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
February 2005, The Journal of pharmacy and pharmacology,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
March 1982, Il Farmaco; edizione scientifica,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
February 2018, Bioorganic & medicinal chemistry letters,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
January 2009, Acta poloniae pharmaceutica,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
June 2021, Bioorganic chemistry,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
March 2022, Molecules (Basel, Switzerland),
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
June 2020, Bioorganic & medicinal chemistry,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
February 2018, European journal of medicinal chemistry,
Xiaoke Gu, and Jing Chen, and Yinpeng Zhang, and Mingyu Guan, and Xin Li, and Qingqing Zhou, and Qinghua Song, and Jingying Qiu
September 2015, Molecules (Basel, Switzerland),
Copied contents to your clipboard!